Home › PeptiDream Announces Collaboration And License Agreement With Lilly To Discover Macrocyclic Peptide Drug Candidates
 

Keywords :   


PeptiDream Announces Collaboration And License Agreement With Lilly To Discover Macrocyclic Peptide Drug Candidates

2013-12-30 05:48:10| drugdiscoveryonline News Articles

PeptiDream Inc, a Tokyo-based biopharmaceutical company (PeptiDream), recenlty announced that they have entered into a Collaboration and License Agreement with US-based Eli Lilly and Company (Lilly) on 19 December 2013

Tags: agreement license drug discover

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.05ICP Group\'s APF Polymer Surfaces Debuts New Website
21.05Woosh Continues Steps Toward Circular Diaper
21.05Ceres Tag names Animal Health Express, Inc. as exclusive supplier
21.05P&G Professional Expands Laundry Care Lineup with Tide Laundry Detergent, Downy Fabric Softener
21.05Xitron introduces new offset prepress workflow
21.05NPPC, Farm Bureau lead coalition to urge Congressional fix to Prop 12
21.05BASF Expands E-coat Manufacturing Facility in Mangalore, India
21.05Tennesse Program to Provide Free Diapers to Families
More »